[RPRX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 585.50%
YoY- 181.02%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 564,690 537,267 567,978 596,000 536,313 538,202 683,971 -11.96%
PBT 806,358 194,377 -4,273 718,000 122,077 351,336 509,089 35.76%
Tax 0 92,373 -9,051 223,000 49,963 123,711 168,334 -
NP 543,987 102,004 4,778 494,340 72,114 227,625 340,755 36.47%
Tax Rate 0.00% -47.52% - -31.06% -40.93% -35.21% -33.07% -
Total Cost 20,703 435,263 563,200 101,660 464,199 310,577 343,216 -84.54%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 96.33 18.99 0.84 82.94 13.45 42.29 49.82 55.01%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS 1.61 0.23 0.01 1.11 0.16 0.51 0.76 64.72%
EPS Diluted 1.21 0.23 0.01 1.11 0.16 0.50 0.76 36.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.